Sleep Effectiveness and Insulin and Glucose Homeostasis
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Eszopiclone (Primary)
- Indications Prediabetic-state; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 04 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 17 Dec 2015 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov record.
- 17 Dec 2015 Planned End Date changed from 1 Aug 2014 to 1 Dec 2016 according to ClinicalTrials.gov record.